Adaptimmune Therapeutics PLC (ADAP)
0.801
-0.01
(-1.69%)
USD |
NASDAQ |
Nov 05, 09:38
Adaptimmune Therapeutics EPS Estimates for Current Quarter
EPS Estimates for Current Quarter Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Estimates for Current Quarter Data
| Date | Value |
|---|---|
| August 12, 2024 | -- |
| August 02, 2024 | -- |
| June 30, 2024 | -- |
| June 12, 2024 | -- |
| May 31, 2024 | -- |
| May 30, 2024 | -- |
| May 15, 2024 | -- |
| March 31, 2024 | -- |
| February 15, 2024 | -- |
| January 04, 2024 | -- |
| December 31, 2023 | -- |
| November 09, 2023 | -- |
| November 08, 2023 | -- |
| September 22, 2023 | -- |
| August 14, 2023 | -- |
| August 10, 2023 | -- |
| August 09, 2023 | -- |
| June 05, 2023 | -- |
| May 19, 2023 | -- |
| Date | Value |
|---|---|
| May 15, 2023 | -- |
| May 12, 2023 | -- |
| April 11, 2023 | -- |
| March 31, 2023 | -- |
| March 07, 2023 | -- |
| March 06, 2023 | -- |
| February 24, 2023 | -- |
| January 04, 2023 | -- |
| December 31, 2022 | -- |
| November 23, 2022 | -- |
| November 11, 2022 | -- |
| November 08, 2022 | -- |
| September 30, 2022 | -- |
| September 09, 2022 | -- |
| September 06, 2022 | -- |
| August 04, 2022 | -- |
| June 30, 2022 | -- |
| May 17, 2022 | -- |
| May 09, 2022 | -- |
Earnings Per Share Estimates Definition
This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.